Europe Contract Research Organization (CRO) Market Research Report Forecast to 2030

Europe Contract Research Organization (CRO) Market Research Report Forecast to 2030


The growth of the Europe contract research organization (CRO) market is attributed to the increasing R&D expenditure in Europe, the rising number of clinical trials, digital transformation in clinical trials, and growing CRO outsourcing in drug development. However, a shortage of skilled and experienced professionals and stringent regulatory policies are anticipated to hamper the market growth.

A contract research organization also called a Clinical Research Organization (CRO), provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services (for both drugs and medical devices). CROs also offer the experience of advancing a new drug or device from its inception to FDA marketing approval to their clients without the drug sponsor needing to maintain a staff for these services. CROs range from huge, international full-service businesses to small, niche specialty groups.

The Europe Contract Research Organization (CRO) market is emerging due to factors the increasing R&D expenditure in Europe, the rising number of clinical trials, and the growing CRO outsourcing in drug development. Additionally, the digital transformation in clinical trials will provide growth opportunities for the market in the future. However, the shortage of skilled and experienced professionals and stringent regulatory policies might hamper the market's growth in the forecast period.

Market Segmentation
In terms of Type, Europe Contract research organization is classified into Phase I, phase II, phase III, and Phase IV clinical trial services.

Based on applications the market is classified into Oncology, Cardiovascular, Autoimmune/Inflammation, Central Nervous System (CNS), Dermatology, Infectious Diseases, and Others.

The end-user industry is made up of Pharmaceutical and Biopharmaceutical Companies, Research Laboratories, and Others.

Regional Analysis
The increasing investment in R&D programs, patent expiration in the healthcare sector, and preference for outsourcing activities due to time & cost constraints are key factors anticipated to drive the Europe Contract Research Organization (CRO) market. In addition, increasing government support to research institutes and companies for R&D activities through grants and funds has further boosted the regional market. For instance, in 2021, the European government invested USD 109 billion in medical and health R&D. This is attributed to the high prevalence of chronic conditions, a fast-growing pharmaceutical market, a treatment-naive patient pool, access to a large, favorable, and harmonized regulatory environment, and strong Intellectual Property (IP) and legal Infrastructure. In addition, the availability of skilled professionals having experience with regulations and numerous large-scale, advanced clinical trial centers and specialized disease centers with therapeutic area expertise is further boosting regional growth.

Major Players
Charles River Laboratories, IQVIA, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., and ICON plc.

Companies Mentioned
Charles River Laboratories
IQVIA
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
and ICON plc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


1 Executive Summary 12
1.1 Overview 12
2 Market Introduction 13
2.1 Definition 13
2.2 Scope Of The Study 13
2.3 Research Objective 13
2.4 Market Structure 14
2.5 Assumptions & Limitations 15
3 Research Methodology 16
3.1 Data Mining 16
3.2 Secondary Research 17
3.3 Primary Research 18
3.4 Breakdown Of Primary Respondents 19
3.5 Forecasting Techniques 19
3.6 Research Methodology For Market Size Estimation 20
3.6.1 Bottom-up Approach 21
3.6.2 Top-down Approach 22
3.7 Data Triangulation 22
3.8 Validation 23
4 Market Dynamics 24
4.1 Overview 24
4.2 Drivers 25
4.2.1 Increasing R&D Expenditure In Europe 25
4.2.2 Rising Number Of Clinical Trials 25
4.2.3 Growing Cro Outsourcing In Drug Development 26
4.3 Restraints 27
4.3.1 Shortage Of Skilled And Experienced Professionals 27
4.3.2 Stringent Regulatory Policies 27
4.4 Opportunity 28
4.4.1 Digital Transformation In Clinical Trials 28
5 Market Factor Analysis 29
5.1 Value Chain Analysis 29
5.1.1 Customer Acquisition (Prepurchase Query) 30
5.1.2 Service Customization 30
5.1.3 Customer Purchase Support 30
5.1.4 Customer Fulfilment & Post-purchase Support 30
5.2 Porter's Five Forces Model 31
5.2.1 Threat Of New Entrants 31
5.2.2 Bargaining Power Of Suppliers 32
5.2.3 Threat Of Substitutes 32
5.2.4 Bargaining Power Of Buyers 32
5.2.5 Intensity Of Rivalry 32
5.3 Impact Of Covid-19 On Contract Research Organization Market 33
5.3.1 Impact On Supply Chain 33
5.3.2 Impact On Pricing 33
5.3.3 Impact On Key Players 33
6 Europe Contract Research Organization (Cro) Market, By Type 34
6.1 Overview 34
6.2 Phase I Trial Services 36
6.3 Phase Ii Trial Services 36
6.4 Phase Iii Trial Services 37
6.5 Phase Iv Trial Services 37
7 Europe Contract Research Organization (Cro) Market, By Application 38
7.1 Overview 38
7.2 Oncology 40
7.3 Cardiovascular 40
7.4 Autoimmune/Inflammation 41
7.5 Central Nervous System (Cns) 41
7.6 Dermatology 42
7.7 Infectious Diseases 42
7.8 Others 43
8 Europe Contract Research Organization (Cro) Market, By End User 44
8.1 Overview 44
8.2 Pharmaceutical And Biopharmaceutical Companies 46
8.3 Research Laboratories 46
8.4 Others 47
9 Europe Contract Research Organization (Cro) Market, By Country 48
9.1 Overview 48
9.2 Germany 51
9.3 Austria 52
9.4 Switzerland 53
9.5 Rest Of Europe 54
10 Competitive Landscape 55
10.1 Overview 55
10.2 Competitive Benchmarking 56
10.3 Major Growth Strategy In The Europe Contract Reseach Organization (Cro) Market 57
10.4 The Leading Players In Terms Of Number Of Developments In Europe Contract Reseach Organization (Cro) Market 57
10.5 Key Development Analysis 58
10.6 Key Developments & Growth Strategies 59
10.6.1 Acquisition 59
10.6.2 Collaboration 59
10.6.3 Partnership 60
10.6.4 Product/Service Launch 60
10.7 Major Players Financial Matrix 61
10.7.1 Sales, 2021 61
11 Company Profiles 62
11.1 Thermo Fisher Scientific Inc. 62
11.1.1 Company Overview 62
11.1.2 Financial Overview 63
11.1.3 Product/Service Offered 63
11.1.4 Key Developments 64
11.1.5 Swot Analysis 64
11.1.6 Key Strategies 64
11.2 Laboratory Corporation Of America Holdings 65
11.2.1 Company Overview 65
11.2.2 Financial Overview 66
11.2.3 Product/Service Offered 66
11.2.4 Key Developments 67
11.2.5 Key Strategies 67
11.3 Icon Plc 68
11.3.1 Company Overview 68
11.3.2 Financial Overview 68
11.3.3 Product/Service Offered 69
11.3.4 Key Developments 69
11.3.5 Swot Analysis 70
11.3.6 Key Strategies 70
11.4 Clario 71
11.4.1 Company Overview 71
11.4.2 Financial Overview 71
11.4.3 Product/Service Offered 71
11.4.4 Key Developments 72
11.4.5 Key Strategies 72
11.5 Galser Sa 73
11.5.1 Company Overview 73
11.5.2 Financial Overview 73
11.5.3 Product/Service Offered 73
11.5.4 Key Developments 74
11.5.5 Key Strategies 74
11.6 Charles River Laboratories 75
11.6.1 Company Overview 75
11.6.2 Financial Overview 76
11.6.3 Products Offered 77
11.6.4 Key Developments 77
11.6.5 Swot Analysis 78
11.6.6 Key Strategies 78
11.7 Parexel International Corporation. 79
11.7.1 Company Overview 79
11.7.2 Financial Overview 79
11.7.3 Products Offered 79
11.7.4 Key Developments 80
11.7.5 Key Strategies 80
11.8 Iqvia 81
11.8.1 Company Overviews 81
11.8.2 Financial Overview 82
11.8.3 Products Offered 82
11.8.4 Key Developments 83
11.8.5 Swot Analysis 83
11.8.6 Key Strategies 83
11.9 Syneos Health 84
11.9.1 Company Overview 84
11.9.2 Financial Overview 85
11.9.3 Products Offered 85
11.9.4 Key Developments 86
11.9.5 Swot Analysis 86
11.9.6 Key Strategies 86
11.10 Quanticate 87
11.10.1 Company Overview 87
11.10.2 Financial Overview 87
11.10.3 Products Offered 87
11.10.4 Key Developments 88
11.10.5 Key Strategies 88
12 Appendix 89
12.1 References 89
12.2 Related Reports 90
List Of Tables
Table 1 List Of Assumptions & Limitations 15
Table 2 Primary Interviews And Information Gathering Process 18
Table 3 Europe Contract Research Organization (Cro) Market, By Type, 2018–2030 (Usd Million) 35
Table 4 Europe Contract Research Organization (Cro) Market, For Phase I Trial Services, By Country, 2018–2030 (Usd Million) 36
Table 5 Europe Contract Research Organization (Cro) Market, For Phase Ii Trial Services, By Country, 2018–2030 (Usd Million) 36
Table 6 Europe Contract Research Organization (Cro) Market, For Phase Iii Trial Services, By Country, 2018–2030 (Usd Million) 37
Table 7 Europe Contract Research Organization (Cro) Market, For Phase Iv Trial Services, By Country, 2018–2030 (Usd Million) 37
Table 8 Europe Contract Research Organization (Cro) Market, By Application, 2018–2030 (Usd Million) 39
Table 9 Europe Contract Research Organization (Cro) Market, For Oncology, By Country, 2018–2030 (Usd Million) 40
Table 10 Europe Contract Research Organization (Cro) Market, For Cardiovascular, By Country, 2018–2030 (Usd Million) 40
Table 11 Europe Contract Research Organization (Cro) Market, For Autoimmune/Inflammation, By Country, 2018–2030 (Usd Million) 41
Table 12 Europe Contract Research Organization (Cro) Market, For Central Nervous System (Cns), By Country, 2018–2030 (Usd Million) 41
Table 13 Europe Contract Research Organization (Cro) Market, For Dermatology, By Country, 2018–2030 (Usd Million) 42
Table 14 Europe Contract Research Organization (Cro) Market, For Infectious Diseases, By Country, 2018–2030 (Usd Million) 42
Table 15 Europe Contract Research Organization (Cro) Market, For Others, By Country, 2018–2030 (Usd Million) 43
Table 16 Europe Contract Research Organization (Cro) Market, By End User, 2018–2030 (Usd Million) 45
Table 17 Europe Contract Research Organization (Cro) Market, For Pharmaceutical And Biopharmaceutical Companies, By Country, 2018–2030 (Usd Million) 46
Table 18 Europe Contract Research Organization (Cro) Market, For Research Laboratories, By Country, 2018–2030 (Usd Million) 46
Table 19 Europe Contract Research Organization (Cro) Market, For Others, By Country, 2018–2030 (Usd Million) 47
Table 20 Europe Contract Research Organization (Cro) Market, By Country, 2018–2030 (Usd Million) 49
Table 21 Europe Contract Research Organization (Cro) Market, By Type, 2018–2030 (Usd Million) 49
Table 22 Europe Contract Research Organization (Cro) Market, By Application, 2018-2030 (Usd Million) 50
Table 23 Europe Contract Research Organization (Cro) Market, By End User, 2018–2030 (Usd Million) 50
Table 24 Germany: Contract Research Organization (Cro) Market, By Type, 2018–2030 (Usd Million) 51
Table 25 Germany: Contract Research Organization (Cro) Market, By Application, 2018–2030 (Usd Million) 51
Table 26 Germany: Contract Research Organization (Cro) Market, By End User, 2018–2030 (Usd Million) 51
Table 27 Austria: Contract Research Organization (Cro) Market, By Type, 2018–2030 (Usd Million) 52
Table 28 Austria: Contract Research Organization (Cro) Market, By Application, 2018–2030 (Usd Million) 52
Table 29 Austria: Contract Research Organization (Cro) Market, By End User, 2018–2030 (Usd Million) 52
Table 30 Switzerland: Contract Research Organization (Cro) Market, By Type, 2018–2030 (Usd Million) 53
Table 31 Switzerland: Contract Research Organization (Cro) Market, By Application, 2018–2030 (Usd Million) 53
Table 32 Switzerland: Contract Research Organization (Cro) Market, By End User, 2018–2030 (Usd Million) 53
Table 33 Rest Of Europe: Contract Research Organization (Cro) Market, By Type, 2018–2030 (Usd Million) 54
Table 34 Rest Of Europe: Contract Research Organization (Cro) Market, By Application, 2018–2030 (Usd Million) 54
Table 35 Rest Of Europe: Contract Research Organization (Cro) Market, By End User, 2018–2030 (Usd Million) 54
Table 36 Major Players In The Europe Contract Research Organization (Cro) Market 55
Table 37 Most Active Players In The Europe Contract Reseach Organization (Cro) Market 57
Table 38 Acquisition 59
Table 39 Collaboration 59
Table 40 Partnership 60
Table 41 Product/Service Launch 60
Table 42 Thermo Fisher Scientific Inc.: Services Offered 63
Table 43 Laboratory Corporation Of America Holdings: Services Offered 66
Table 44 Laboratory Corporation Of America Holdings: Key Developments 67
Table 45 Icon Plc: Services Offered 69
Table 46 Icon Plc: Key Developments 69
Table 47 Clario: Services Offered 71
Table 48 Galser Sa: Services Offered 73
Table 49 Charles River Laboratories.: Services Offered 77
Table 50 Charles River Laboratories: Key Developments 77
Table 51 Parexel International Corporation.: Services Offered 79
Table 52 Parexel International Corporation.: Key Developments 80
Table 53 Iqvia: Products Offered 82
Table 54 Iqvia: Key Developments 83
Table 55 Syneos Health.: Services Offered 85
Table 56 Quanticate: Services Offered 87
Table 57 Quanticate: Key Developments 88
List Of Figures
Figure 1 Market Synopsis 12
Figure 2 Europe Contract Research Organization (Cro) Market Structure 14
Figure 3 Bottom-up And Top-down Approaches 21
Figure 4 Market Dynamics: Europe Contract Research Organization (Cro) Market 24
Figure 5 Driver Impact Analysis 26
Figure 6 Restraint Impact Analysis 27
Figure 7 Value Chain Analysis: Europe Contract Research Organization (Cro) Market 29
Figure 8 Porter's Five Forces Analysis: Europe Contract Research Organization (Cro) Market 31
Figure 9 Europe Contract Research Organization (Cro), By Type, 2021 & 2030 (Usd Million) 35
Figure 10 Europe Contract Research Organization (Cro) Market, By Application, 2021 & 2030 (Usd Million) 39
Figure 11 Europe Contract Research Organization (Cro) Market, By End User, 2021 & 2030 (Usd Million) 45
Figure 12 Europe Contract Research Organization (Cro) Market, By Country, 2021 & 2030 (Usd Million) 49
Figure 13 Benchmarking Of Major Competitors 56
Figure 14 Major Strategy Adopted By Key Players In The Contract Reseach Organization (Cro) Market 57
Figure 15 Europe Contract Reseach Organization (Cro) Market: Competitive Landscape 58
Figure 16 Sales, 2021 (Usd Million) 61
Figure 17 Thermo Fisher Scientific Inc.: Financial Overview 63
Figure 18 Thermo Fisher Scientific Inc.: Swot Analysis 64
Figure 19 Laboratory Corporation Of America Holdings: Financial Overview Snapshot 66
Figure 20 Icon Plc: Financial Overview Snapshot 68
Figure 21 Icon Plc: Swot Analy 70
Figure 22 Charles River Laboratories Financial Overview Snapshot 76
Figure 23 Charles River Laboratories: Swot Analysis 78
Figure 24 Iqvia: Financial Overview Snapshot 82
Figure 25 Iqvia: Swot Analysis 83
Figure 26 Syneos Health: Financial Overview Snapshot 85
Figure 27 Syneos Health: Swot Analysis 86

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings